CCHF Virus Vaccine
Crimean-Congo Haemorrhagic Fever
Pre-clinicalActive
Key Facts
Indication
Crimean-Congo Haemorrhagic Fever
Phase
Pre-clinical
Status
Active
About Oxford Expression Technologies
Oxford Expression Technologies (OET) is a private biotechnology company founded in 2001 (incorporated 2007) as a spin-out from Oxford Brookes University and the Natural Environment Research Council. The company has established itself as a leading global provider of baculovirus expression products and services, centered on its proprietary flash BAC™ platform for high-throughput recombinant protein and virus-like particle production. OET leverages its expertise in insect, mammalian, and bacterial expression systems to serve clients in drug discovery, vaccine development, and diagnostics, while also pursuing its own internal vaccine development programs through grant-funded collaborations.
View full company profileTherapeutic Areas
Other Crimean-Congo Haemorrhagic Fever Drugs
| Drug | Company | Phase |
|---|---|---|
| CCHF Virus Program | JLP Health | Research |